Human BioSystems Completes Platelet Testing At Second Independent Laboratory
PALO ALTO, CALIFORNIA--(MARKET WIRE)--Jul 5, 2006 -- Human BioSystems ("HBS") (OTC BB:HBSC.OB - News), a developer of preservation platforms for organs and other biomaterials, specializing in the development of proprietary above zero ("HBS-AZ") and below zero ("HBS-BZ") organ and tissue preservation systems and methods for preserving blood platelets, announced today that it has completed blood platelet testing at a second independent laboratory.